Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR -Activating Mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR -Activating Mutation

Published:2017-11 Issue:11 Volume:15 Page:1310-1315
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:en
Short-container-title:J Natl Compr Canc Netw

Author:

Rodríguez-Moreno Juan Francisco,Apellaniz-Ruiz María,Roldan-Romero Juan María,Durán Ignacio,Beltrán Luis,Montero-Conde Cristina,Cascón Alberto,Robledo Mercedes,García-Donas Jesus,Rodríguez-Antona Cristina

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. Renal Cell Cancer – Insights in Drug Resistance Mechanisms;Anticancer Research;2023-11

3. Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition;International Journal of Cancer;2023-06

4. Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study;Oncology;2023

5. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion;Journal of Clinical Oncology;2022-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP